In a landmark policy decision, the Centers for Medicare and Medicaid Services (CMS) has revised its CGM coverage policy to allow Medicare beneficiaries use of smartphone apps along with their covered therapeutic CGMs. Huge kudos to the many orgs such as ADA, AACE, AADE, Endocrine Socety and DPAC for being on top of this issue and continuing to advocate on it, as recently as last w
eek during a meeting with CMS officials.
Based on input from patients and other stakeholders, The Centers for Medicare & Medicaid Services (CMS) is announcing important changes in its written policies regarding how Medicare covers continuous glucose monitors (CGMs). These changes are consistent with the Agency’s approach of putting patients first and incentivizing innovation and use of e-technology.